US-based digital healthcare platform Xealth has completed a $14m series A round following a $3m extension from investors including healthcare providers Atrium Health, Cleveland Clinic and MemorialCare Health System.
Incubated at Providence St. Joseph Health in 2017, Xealth has developed software that healthcare teams can use to order and prescribe digital care treatments such as apps, devices or media content that can help sick patients recover or address their conditions.
The round’s $11m first tranche closed in April 2019, following commitments from pharmaceutical firm Novartis, electronics and medical technology producer Philips, medical device maker ResMed and McKesson Ventures, the corporate venturing arm of medical product distributor McKesson.
Providence Ventures, a subsidiary of healthcare system Providence St. Joseph, also took part in the first tranche, as did care provider UPMC, Threshold Ventures and a partnership between hospital Froedtert and the Medical College of Wisconsin, while MemorialCare invested through its MemorialCare Innovation Fund.
Providence Ventures, UPMC, Froedtert Medical College of Wisconsin Health Network and Threshold Ventures (then known as DFJ Venture) previously contributed to the company’s $8.5m seed round in mid-2017.